From Medscape Oncology

Coverage From The

European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting 2019

March 24 - 27, 2019; Frankfurt, Germany

March 24 - 27, 2019 Frankfurt, Germany

Conference News

Related Coverage 

  • Three Ways to Address BMT Patients in Community Three Ways to Address BMT Patients in Community Moving to community care may imperil blood and bone marrow transplant patients. Three nurse-led studies show how the challenge can be met.
  • Treosulfan Better Than Busulfan in Prep for HSCT Treosulfan Better Than Busulfan in Prep for HSCT Older and sicker patients with acute myeloid leukemia undergoing stem cell transplant may fare better if they are given a treosulfan- rather than busulfan-based regimen, German scientists have shown.
  • Cord Blood Instead of Bone Marrow for HSCT for Blood Cancers Cord Blood Instead of Bone Marrow for HSCT for Blood Cancers Clinicians should get over their preconceptions about sourcing stem cells from cord blood for transplants in hematologic malignancies, as it can achieve good short- and long-term outcomes, says an expert in the field.

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.